A new study has shed light on dementia demonstrating that higher dementia risk is linked to more use of common drugs.
The study conducted at University of Washington suggested that increased risk for developing dementia, including Alzheimer's disease is linked to taking commonly used medications with anticholinergic effects at higher doses or for a longer time.
Shelly Gray, PharmD, MS, the first author of the report, said that older adults should be aware that many medications including some available without a prescription, such as over-the-counter sleep aids-have strong anticholinergic effects and they should tell their health care providers about all their over-the-counter use.
Gray said that no one should stop taking any therapy without consulting their health care provider and health care providers should regularly review their older patients drug regimens including over-the-counter medications to look for chances to use fewer anticholinergic medications at lower doses.
Gray added that if providers need to prescribe a medication with anticholinergic effects because it is the best therapy for their patient and they should use the lowest effective dose, monitor the therapy regularly to ensure it is working, and stop the therapy if it's ineffective.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
